0002086249-25-000001.txt : 20250917 0002086249-25-000001.hdr.sgml : 20250917 20250917171931 ACCESSION NUMBER: 0002086249-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250917 DATE AS OF CHANGE: 20250917 EFFECTIVENESS DATE: 20250917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Upstream Biotechnology, Inc. CENTRAL INDEX KEY: 0002086249 ORGANIZATION NAME: EIN: 823621137 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-557862 FILM NUMBER: 251321018 BUSINESS ADDRESS: STREET 1: 701 W. MAIN STREET, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 252-551-1088 MAIL ADDRESS: STREET 1: 701 W. MAIN STREET, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0002086249 Upstream Biotechnology, Inc. 701 W. MAIN STREET, SUITE 200 DURHAM NC NORTH CAROLINA 27701 252-551-1088 NORTH CAROLINA None None Corporation true George H. Greene c/o Upstream Biotechnology, Inc. 701 W. Main St., Suite 200 Durham NC NORTH CAROLINA 27701 Executive Officer Director Xinnian Dong c/o Upstream Biotechnology, Inc. 701 W. Main St., Suite 200 Durham NC NORTH CAROLINA 27701 Director Xiao-fang Wang c/o Upstream Biotechnology, Inc. 701 W. Main St., Suite 200 Durham NC NORTH CAROLINA 27701 Director Dr. Wang resigned as a director in connection with the Offering. Karen LeVert c/o Upstream Biotechnology, Inc. 701 W. Main St., Suite 200 Durham NC NORTH CAROLINA 27701 Director Ms. LeVert was elected a director in connection with the Offering. Other Technology Decline to Disclose 06b false 2025-08-26 false true false 0 1625000 625000 1000000 false 3 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Upstream Biotechnology, Inc. /s/ George H. Greene George H. Greene Chief Executive Officer 2025-09-03